Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Workers' Comp
Blog
It's time to rethink how we talk about Specialty Networks
Let’s say goodbye to the term ancillary when it comes to caregiving in workers’ compensation.
Workers' Comp
White Paper
How Remote Ergonomics Assessments Help Prevent Home Office Injuries
For many employees, remote work started as a temporary displacement from office worksites due to COVID-related shutdowns.
PDF
News Release
Apricus Launch Announcement
Apricus combines the best of two industry-leading specialty networks. Integration efforts deliver bigger, broader specialty networks capability.
Workers' Comp
News Release
Apricus Combines the Best of Two Industry-Leading Specialty Networks
Integration efforts deliver bigger, broader specialty networks capability.
Workers' Comp
News Release
Apricus Combines the Best of Two Industry-Leading Specialty Networks
Integration efforts deliver bigger, broader specialty networks capability
Workers' Comp
Article
WorkCompWire: Case Managers Help Alleviate Covid-19’s Head-on Collision with the Opioid Epidemic
As 2020 began, a persistent opioid overdose epidemic was near the forefront of a list of national concerns in the United States. Some 20 million Americans are reported to have a subs